FindTrial
Sign In

Research on Precise Treatment Decision-making for T1 Colorectal Cancer Assisted by Artificial Intelligence: Prediction of Lymph Node Metastasis Risk and Guidance for Surgical Decision-making after ESD

Research on Precise Treatment Decision-making for T1 Colorectal Cancer Assisted by Artificial Intelligence: Prediction of Lymph Node Metastasis Risk and Guidance for Surgical Decision-making after ESD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104618
Enrollment
Unknown
Registered
2025-06-19
Start date
2025-06-15
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T1 Colorectal cancer

Interventions

Lymph node metastasis and non-metastasis:none

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with colorectal cancer diagnosed pathologically as T1

Exclusion criteria

Exclusion criteria: (1) Those with advanced cancer at the same or different times; (2) Those with familial adenomatous polyposis, Lynch syndrome or ulcerative colitis; (3) Those who have received chemotherapy or radiotherapy before the operation.

Design outcomes

Primary

MeasureTime frame
Lymph node metastasis;Area under the receiver operating characteristic curve;—

Secondary

MeasureTime frame
Sensitivity;Specificity; Calibration slope & intercept;Net Benefit, Decision Curve Analysis;—

Countries

China

Contacts

Public ContactLiu Feng

Shanghai Tenth People's Hospital

drliuffeng@hotmail.com+86 136 8197 3214

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026